Biomarkers - Xconomy

by in

Entry	Author	Date	Location
City Hill Leads $6M Financing to Pioneer RA Diagnostics at Ignyta	Bruce V. Bigelow	12/31/12	San Diego
Genome Dynamics on Taking Overactive Bladder Biomarker Tests Mainstream	Sarah Schmid	07/16/12	Detroit
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients	Ryan McBride	12/10/10	Boston
Aveo Pharma to Get $25M from OSI	Ryan McBride	12/01/10	Boston
Biogen Strikes Deal with Knopp for ALS Drugs, Selecta Gets New CEO, Avantra Scores $7M, & More Boston-Area Life Sciences News	Erin Kutz	08/20/10	Boston
On-Q-ity, Led by Former Genzyme Exec, Takes on “Diagnostic Black Hole” in Cancer	Ryan McBride	07/07/10	Boston
Elias Zerhouni Talks Public Health Challenges, Culture Wars at WBBA Annual Meeting	Gregory T. Huang	11/06/09	Seattle
On-Q-ity Raises $21M in A Round for Personalized Cancer Testing	Ryan McBride	11/03/09	Boston
Aushon Secures $6.5M Financing to Help Support Acquisition	Robert Buderi	03/30/09	Boston
Amgen Looks to Biomarkers to Boost Its Batting Average in Developing New Drugs	Luke Timmerman	08/07/08	National
Riding the Biomarker Wave: Aveo Snags Eli Lilly Deal	Malorye Allison	12/05/07	Boston
SeraCare Rebuilding Image and a Brand New Milford Headquarters Too	Malorye Allison	10/16/07	Boston
Page 1 of 1

Xconomy National